219 related articles for article (PubMed ID: 23018875)
1. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Karamitopoulou E; Zlobec I; Kölzer V; Kondi-Pafiti A; Patsouris ES; Gennatas K; Lugli A
Mod Pathol; 2013 Feb; 26(2):295-301. PubMed ID: 23018875
[TBL] [Abstract][Full Text] [Related]
2. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Horcic M; Koelzer VH; Karamitopoulou E; Terracciano L; Puppa G; Zlobec I; Lugli A
Hum Pathol; 2013 May; 44(5):697-705. PubMed ID: 23159156
[TBL] [Abstract][Full Text] [Related]
3. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
5. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
[TBL] [Abstract][Full Text] [Related]
6. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.
Wang LM; Kevans D; Mulcahy H; O'Sullivan J; Fennelly D; Hyland J; O'Donoghue D; Sheahan K
Am J Surg Pathol; 2009 Jan; 33(1):134-41. PubMed ID: 18971777
[TBL] [Abstract][Full Text] [Related]
7. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO
Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282
[TBL] [Abstract][Full Text] [Related]
8. Tumour border configuration in colorectal cancer: proposal for an alternative scoring system based on the percentage of infiltrating margin.
Karamitopoulou E; Zlobec I; Koelzer VH; Langer R; Dawson H; Lugli A
Histopathology; 2015 Oct; 67(4):464-73. PubMed ID: 25648412
[TBL] [Abstract][Full Text] [Related]
9. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
[TBL] [Abstract][Full Text] [Related]
10. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
11. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
12. Tumour budding: a promising parameter in colorectal cancer.
Lugli A; Karamitopoulou E; Zlobec I
Br J Cancer; 2012 May; 106(11):1713-7. PubMed ID: 22531633
[TBL] [Abstract][Full Text] [Related]
13. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
14. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
15. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.
Graham RP; Vierkant RA; Tillmans LS; Wang AH; Laird PW; Weisenberger DJ; Lynch CF; French AJ; Slager SL; Raissian Y; Garcia JJ; Kerr SE; Lee HE; Thibodeau SN; Cerhan JR; Limburg PJ; Smyrk TC
Am J Surg Pathol; 2015 Oct; 39(10):1340-6. PubMed ID: 26200097
[TBL] [Abstract][Full Text] [Related]
16. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma.
Aboelnasr LS; El-Rebey HS; Mohamed A; Abdou AG
Turk Patoloji Derg; 2023; 39(1):83-93. PubMed ID: 35642343
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method.
Takamatsu M; Kawachi H; Yamamoto N; Kobayashi M; Toyama Y; Maekawa T; Chino A; Saito S; Ueno M; Takazawa Y; Ishikawa Y
Mod Pathol; 2019 May; 32(5):675-683. PubMed ID: 30552417
[TBL] [Abstract][Full Text] [Related]
19. Budding, tumor-infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in World Health Organization low-grade colorectal cancer with impact on survival.
Lang-Schwarz C; Melcher B; Haumaier F; Schneider-Fuchs A; Lang-Schwarz K; Krugmann J; Vieth M; Sterlacci W
Hum Pathol; 2019 Jul; 89():81-89. PubMed ID: 31054898
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
